PAR21: Levalbuterol Use is Associated with Decreased Health Care Costs in Patients with More Severe Asthma (Englisch)
- Neue Suche nach: Huse, D.
- Neue Suche nach: McLoney, A.
- Neue Suche nach: Yeager, B.
- Neue Suche nach: Cerasoli, F.
- Neue Suche nach: Huse, D.
- Neue Suche nach: McLoney, A.
- Neue Suche nach: Yeager, B.
- Neue Suche nach: Cerasoli, F.
In:
VALUE IN HEALTH
;
4
, 2
;
82
;
2001
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PAR21: Levalbuterol Use is Associated with Decreased Health Care Costs in Patients with More Severe Asthma
-
Beteiligte:Huse, D. ( Autor:in ) / McLoney, A. ( Autor:in ) / Yeager, B. ( Autor:in ) / Cerasoli, F. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 4, 2 ; 82
-
Verlag:
- Neue Suche nach: VALUE IN HEALTH
-
Erscheinungsdatum:01.01.2001
-
Format / Umfang:82 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 4, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 47
-
EM1: Risk Attitude: Association With Magnitude Of Risk and Patient CharacteristicsSinger, M. E. / Beaird, H. / Miller, L. A. N. et al. | 2001
- 47
-
EM2: The Impact of Hospital Costing Methods on Statistical Power in Multinational Clinical TrialsReed, S. D. / Friedman, J. Y. / Malenbaum, J. H. / Gnanasakthy, A. / Schulman, K. A. et al. | 2001
- 48
-
EM3: Response Bias Among Likely Clinical Trial ParticipantsMcDonnell, D. D. / Donohue, J. A. et al. | 2001
- 48
-
MD1: Cost-Effectiveness of Airline Defibrillators: Is Peace of Mind More Important Than Saving Lives?Cram, P. / Vijan, S. / Wolbrink, A. M. / Fendrick, A. M. et al. | 2001
- 48
-
EM4: Can Unit Costs Be Compared Across Western European Countries?Brown, R. / Hutton, J. / Nuijten, M. et al. | 2001
- 49
-
MD4: Inclusion of Indirect Cost in Economic Outcomes Analyses of Medical Devices: How Important Is It?Subramanian, S. / Justason, B. J. et al. | 2001
- 49
-
MD3: The Diagnostic Accuracy of 18FDG-PET In Patients With Recurrent Papillary or Follicular Thyroid Cancer: A Systematic ReviewHooft, L. / Hoekstra, O. S. et al. | 2001
- 49
-
MD2: Analysis of The Impact of Assistive Living Devices on Self-Assessed Health Status RatingRodney, A. B. / Xiao, H. / Robertson, T. et al. | 2001
- 50
-
QL1: Does Socioeconomic Status Affect The Valuation Of Health?Asada, Y. / Stout, N. K. / Kind, P. et al. | 2001
- 50
-
QL2: Logical Consistency and the Valuation of Health: An Analysis Of US Survey DataCraig, B. M. / Kind, P. et al. | 2001
- 51
-
HP1: Ethnic Disparity of Combination Ribavirin/Interferon Alfa-2b Prescribing Among Hepatitis C-Infected Members in a Managed Care Organization (MCO)Phillips, A. L. / Schaffer, M. / Mansukani, S. et al. | 2001
- 51
-
QL3: Quality Of Life in Product Labeling: A Review of Marketed Drug ProductsChopra, T. / Shah, S. N. / McLaughlin-Miley, C. / Hinton, J. et al. | 2001
- 51
-
QL4: Quality Of Life Messages in Prescription Drug Advertisements in Leading Medical Journals, 1990-99Zivin, K. / Neumann, P. et al. | 2001
- 52
-
HP2: The Role Of Outlier Payments in Medicare Patients with Severe SepsisCooper, L. M. / Linde-Zwirble, W. T. et al. | 2001
- 52
-
HP3: Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: Evaluation of 30 Months of ExperienceAtherly, D. E. / Sullivan, S. D. / Fullerton, D. S. / Sturm, L. L. et al. | 2001
- 53
-
CN1: Utilities of Metastatic Breast Cancer Patients (PT) Treated With Taxanes Compared to Utilities of Oncology Nurses (NUR)Hauser, R. / Theriault, R. / Wilson, J. / Shepherd, M. / Lawson, K. / Koeller, J. et al. | 2001
- 53
-
CN2: Effect of Including (Versus Excluding) Fates Worse Than Death on Utility MeasurementFranic, D. M. / Pathak, D. S. et al. | 2001
- 53
-
HP4: Assessing Lifestyle Drugs for Drug Benefit Formularies: A Cost-Utility Analysis Of Orlistat and Sibutramine for the Treatment of Obesity in AdultsTrakas, K. / Oh, P. / Leiter, L. / Shear, N. H. et al. | 2001
- 54
-
CN3: Cost-Effectiveness Analysis of Irinotecan+5FU/FA Alone as First-Line Therapy in Advanced Colorectal Cancer in the UKBrown, R. / Sorensen, S. / Burrell, A. / Bearne, A. et al. | 2001
- 54
-
CN4: Economic Evaluation of Gemzar/Cisplatin Relative to Other Cisplatin Based Treatments for Non Small Cell Lung (NSCLC) Cancer In The UKBotwood, N. / McKendrick, J. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 55
-
CV2: Indirect Comparisons of Drugs Using Meta-Analysis: Validation of ResultsRoss, S. D. / Klawansky, S. / Allen, I. E. et al. | 2001
- 55
-
CV3: Do Short-Acting Opiates in Off-Pump Bypass Surgery Reduce Length of Stay or Total Hospital Costs?Reddy, P. / Feret, B. / Kulicki, L. / Jordan, S. / Donahue, S. / Quercia, R. et al. | 2001
- 55
-
CV1: The Value of Compliance: Evidence From Two Patient CohortsMcGuigan, K. A. / Sokol, M. / Yao, J. / Haynes, J. / Qian, Q. / Boscarino, J. / Epstein, R. et al. | 2001
- 56
-
CV5: The Cost-Effectiveness of Lifetime Factor VIII Prophylaxis in the Treatment of Severe Hemophilia ACharles, R. A. / Hay, J. et al. | 2001
- 56
-
CV4: Using UK Observational Data to Identify Possibilities for the Cost-Effective Improvement of the Treatment Of Atrial FibrillationPiercy, J. / James, P. / Baum, D. / Kuester, L. et al. | 2001
- 57
-
CV7: Cost-Effectiveness of Cardiovascular Disease (CVD) Prevention by Reducing Postprandial HyperglycemiaGlick, H. / Qiao, Q. / Grueger, J. et al. | 2001
- 57
-
CV8: Work-Related Outcomes of Patients Six Months After Myocardial InfarctionErickson, S. R. / McBurney, C. R. / Kline-Rogers, E. M. / Cooper, J. V. / Mani, O. C. M. / Eagle, K. A. et al. | 2001
- 57
-
CV6: Economic Evaluation of Dalteparin, Enoxaparin and Unfractionated Heparin in the Treatment of Deep Vein ThrombosisRisebrough, N. A. / Mittmann, N. et al. | 2001
- 58
-
DG1: The Relationship of Diabetes Symptoms and Health-Related Quality Of LifePfalzgraf, A. R. / Nau, D. P. et al. | 2001
- 58
-
DG2: The Incremental Cost of Diabetes in Chronic Illness Co-OccurrencesGaris, R. I. / Farmer, K. C. / Arora, M. et al. | 2001
- 59
-
DG3: A Retrospective Evaluation of Nonsteroidal Anti-Inflammatory Drug-Induced Gastrointestinal Complications Among Adults in a Managed Care Health PlanDodd, M. A. / D Angio, R. / Gupchup, G. V. / Nelson, C. et al. | 2001
- 59
-
DG4: Disease Severity Determines Cost of Gastroesophageal Reflux Disease in a Midwest USA Health Care PlanBrelje, T. / Heaton, A. / Martin, S. / Bhattacharjya, A. / Dodd, S. / Thornhill, J. et al. | 2001
- 59
-
ID1: Development of a Stochastic Decision Analysis Model of Treatment of Pyelonephritis from the Results of an RCTDavey, P. / Wang, J. / Claxton, K. / Fenwick, E. / Sculpher, M. / Talan, D. et al. | 2001
- 60
-
ID2: Health Values for the Lipodystrophy SyndromeLenert, L. A. / Fedderson, M. / Sturley, A. / Lee, D. et al. | 2001
- 60
-
ID3: Cost-Effectiveness Analysis of An Intranasal Influenza Vaccine for Healthy ChildrenLuce, B. / Zangwill, K. / Palmer, C. / Mendelman, P. / Yan, L. / Wolff, M. / Cho, I. / Iacuzio, D. / Belshe, B. et al. | 2001
- 61
-
MH2: Future Employability: A New Approach to Cost-Effectiveness Analysis of Antipsychotic TherapyGanguly, R. / Miller, L. S. / Martin, B. C. et al. | 2001
- 61
-
MH1: The Impact of Second-Generation Antipsychotic Medications on Ambulatory Patients With SchizophreniaMulani, P. M. / McCombs, J. et al. | 2001
- 61
-
ID4: The Confusion Between Septicemia and Severe SepsisLinde-Zwirble, W. T. / Ball, D. E. / Cooper, L. M. / Lidicker, J. / Angus, D. C. et al. | 2001
- 62
-
MH3: Clinical Assessment of Quality of Life Among Schizophrenia Patients With Deficit SyndromeRusso, P. / Kirkpatrick, B. et al. | 2001
- 62
-
MH4: Application of the Rasch Model to the SF36 Mental Health 5 Item Scale (MH5)Perneger, T. V. / Bovier, P. A. et al. | 2001
- 63
-
MS1: Cost-Effectiveness of Interventions For Lateral Epicondylitis: Results from a Randomized Controlled Trial in Primary CareKorthals-de Bos, I. B. C. / Smidt, N. / Tulder, M. / Bouter, L. et al. | 2001
- 63
-
MS2: Responsiveness to Change of the SF-36 in Rapolo, a Longitudinal Study of Rheumatoid Arthritis Patients Treated With EtanerceptLubeck, D. P. / Yelin, E. / Katz, P. / Roepke, L. / Wanke, L. A. / Buatti, M. et al. | 2001
- 63
-
MS3: Correlation of a Generic Health-Related Quality of Life Questionnaire and Self-Administered Rheumatoid Arthritis Disease Activity InstrumentKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 64
-
MS4: A Systematic Review of Health State Values for Osteoporosis Related ConditionsBrazier, J. E. / Green, C. / Kanis, J. et al. | 2001
- 64
-
RS1: Outcome Assessment in Pediatric Asthma: A Comparison of Symptom-Free Time and Multi-Attribute ScaleChiou, C. F. / Weaver, M. R. / Bell, M. A. et al. | 2001
- 65
-
RS2: Using Self-Administered Direct TTO Questions to Elicit Utility Values for Asthmatic Patients With Different Severity of DiseaseSzende, A. / Meszaros, A. / Berta, G. Y. / Stahl, E. / Svensson, K. et al. | 2001
- 65
-
RS4: A Model-Based Evaluation of Inhaled Steroids in Mild-To-Moderate AsthmaPaltiel, A. / Fuhlbrigge, A. / Kitch, B. / Weiss, S. / Neumann, P. / Kuntz, K. et al. | 2001
- 65
-
RS3: Psychometric Evaluation of the CAP-SYM Questionnaire: A New, Patient-Based Measure of Symptoms in Community Acquired PneumoniaLamping, D. / Schroter, S. / Sagnier, P. P. / Duprat-Lomon, I. et al. | 2001
- 66
-
PAM1: Joint Counts in Patients with New Onset Rheumatoid Arthritis: Patient vs. Physician AssessmentKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 66
-
PAM2: An Economic Evaluation of Osteoporosis Medication Use Patterns in a Managed Care Organization: A Time to Fracture AnalysisChen, K. S. / White, T. J. / Chang, E. et al. | 2001
- 67
-
PAM4: Use of COX 2 NSAIDS in Subjects Without Risk of Gastrointestinal Side EffectsHarley, C. R. et al. | 2001
- 67
-
PAM5: Investigating the Construct Validity of a Disease Specific and a General Quality of Life Instruments of Patients with Rheumatoid ArthritisLovas, K. / Szende, A. / Balint, G. / Szebenyi, B. / Hejj, G. et al. | 2001
- 67
-
PAM3: The Cost of Osteoporotic Fractures in the United KingdomBurge, R. T. / Worley, D. / Johansen, A. / Bose, U. et al. | 2001
- 68
-
PAM6: Cost-Effectiveness of Rofecoxib Versus NSAIDs in the Treatment of OsteoarthritisSullivan, P. / Hay, J. et al. | 2001
- 68
-
PAM8: Cost Comparison of Treating Osteoporosis Patients with Estrogens or Selective Estrogen Receptor Modulator in a Managed Care PopulationLiao, E. / Sweazy, L. / Huse, D. et al. | 2001
- 68
-
PAM7: The Correlation Between Arthritis Specific Measures and SF-36 Scales in Rheumatoid Arthritis PatientsLubeck, D. P. / Yelin, E. / Katz, P. / Roepke, L. / Wanke, L. A. / Buatti, M. et al. | 2001
- 69
-
PAM9: Cost Comparison of Treating Rheumatoid Arthritis Patients with COX-2 Inhibitors or NSAIDs in a Managed Care PopulationLiao, E. / Kester, G. / Huse, D. et al. | 2001
- 69
-
PAM10: The Impact of Early Rheumatoid Arthritis on ProductivityKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 70
-
PAM13: A Cost-Effectiveness Model Comparing Celecoxib and Rofecoxib to Traditional NSAIDs for Osteoarthritis TreatmentSchaefer, M. G. / Morreale, A. P. / Plowman, B. K. et al. | 2001
- 70
-
PAM11: Applying Background Risk Distribution to Evaluate the Cost-Effectiveness of Three Preventive Drug Therapies for Osteoporotic FracturesGao, X. / Madhavan, S. / Nau, D. / Ambegaonkar, A. / Islam, S. / Rosenbluth, S. / Amonkar, M. et al. | 2001
- 70
-
PAM12: Cost-Minimization Analysis of the Treatment of Rheumatoid Arthritis with Leflunomide in Comparison with the Combination of Infliximab and MethotrexateRubio-Terres, C. / Dominguez-Gil, A. et al. | 2001
- 71
-
PAM15: Evaluating Direct and Indirect Measures of Utility: Stability of the SF-6D in a Rheumatoid Arthritis PopulationCrawford, B. / Brazier, J. E. et al. | 2001
- 71
-
PAM14: Treatment with Leflunomide Improves the Utility of Patients with Active Rheumatoid Arthritis: An Application of the SF-6DCrawford, B. / Brazier, J. E. / Strand, V. / Doyle, J. et al. | 2001
- 71
-
PAM16: Cost Impact of COX-2 Inhibitors in a Managed Care Plan: Implications for Formulary Decision-MakingAtherly, D. E. / Fullerton, D. S. / Sturm, L. L. / Bryant, A. / Sullivan, S. D. et al. | 2001
- 72
-
PAM18: Performance Assessment of Two Fatigue Instruments in an Early Rheumatoid Arthritis CohortDrabinski, A. / Kim, S. S. / Williams, G. / Formica, C. et al. | 2001
- 72
-
PAM17: Important Issues in Number Needed to Treat Analysis in Osteoporosis TreatmentKemner, J. E. et al. | 2001
- 73
-
PAM20: Cost-Effectiveness of Acetylcisteine and Dimethylsulphoxide (DMSO) 50% for the Treatment of Patients with Reflex Sympathic Dystrophyvan Dieten, H. E. / Perez, R. S. / Tulder, M. W. / Boers, M. / Zuurmond, W. W. / de Lange, J. J. / Vondeling, H. et al. | 2001
- 73
-
PAM21: Manual Therapy is More Cost-Effective than Physical Therapy and GP Care for Patients with Neck PainKorthals-de Bos, I. B. / Hoving, J. / Tulder, M. / Bouter, L. et al. | 2001
- 73
-
PAM19: A Review of Functional Status Measures for Workers with Upper Extremity DisordersSalerno, D. F. / Copley-Merriman, C. / Taylor, T. N. / Shinogle, J. / Schulz, R. M. et al. | 2001
- 74
-
PAM22: Studying Predictors of Fractures Among Omnicare Nursing Home ResidentsOderda, G. M. / Gause, D. / Stuart, B. / Erwin, G. et al. | 2001
- 74
-
PAM23: Vertebral Fractures Among Glucocorticoid Patients Significantly Increase Medical Care CostsMeyer, J. W. / Burge, R. T. / Steinbuch, M. et al. | 2001
- 75
-
PAR1: Cost of Asthma in Children in VladivostokProsekova, E. / Geltzer, B. / Dercach, V. / Bogdanovskiy, P. et al. | 2001
- 75
-
PAR2: Use of Respiratory Assist Devices by Medicare BeneficiariesSilverman, B. G. et al. | 2001
- 75
-
PAR3: The Standardized Asthma-Related Quality of Life Questionnaire (AQLQ-S): Does Socioeconomic Status Effect Measurements?Lynd, L. D. / Guh, D. / Pare, P. / Anis, A. et al. | 2001
- 76
-
PAR4: Comparison of Two Quality of Life Instruments in Patients with Chronic Obstructive Pulmonary DiseaseAubert, R. E. / Alemayehu, B. / Feifer, R. et al. | 2001
- 76
-
PAR5: Direct and Indirect Costs of Respiratory InfectionsBirnbaum, H. G. / Morley, M. A. / Greenberg, P. E. / Cifaldi, M. / Colice, G. L. et al. | 2001
- 77
-
PAR8: A Cost-Effectiveness Analysis Comparing Levalbuterol and Albuterol in the Treatment of Moderate to Severe AsthmaCarter, C. T. / McGee, M. D. et al. | 2001
- 77
-
PAR7: Validation of a Model of Severity of Illness in Chronic Respiratory DiseaseSullivan, P. / Nichol, M. et al. | 2001
- 77
-
PAR6: Prophylactic Medication Utilization and Health Care Costs in Older Adults with Chronic Pulmonary AilmentsBalkrishnan, R. / Christensen, D. / Bowton, D. et al. | 2001
- 78
-
PAR11: The Long-Term Societal Economic and Humanistic Benefits of Treating Acute Exacerbations of Chronic Bronchitis (AECB) with Gemifloxacin Versus ClarithromycinHalpern, M. / Kirsch, J. M. / Palmer, C. / Zodet, M. / Wilson, R. et al. | 2001
- 78
-
PAR9: Validation of a Rating Instrument Assessing the Inhalation Skills of Children with AsthmaPradel, F. G. / Weiss, S. / Tsoukleris, M. / Bollinger, M. B. / Fahlman, C. et al. | 2001
- 78
-
PAR10: Implementing Rasch Analysis in Psychometric Evaluation of Patient-Physician Interaction ScaleDalal, M. / Smith, E. / Lambert, B. / Olopade, C. / Crawford, S. et al. | 2001
- 79
-
PAR12: Prospective Use of Web Based Technology to Evaluate Health Outcomes in a Large Cohort of Severe or Difficult to Treat AsthmaticsDolan, C. M. / Fisher, K. A. / Johnson, C. / Fraher, K. E. / Rothermich, E. A. / Fine, J. T. / Weiss, S. T. / Wenzel, S. et al. | 2001
- 79
-
PAR13: Hypothetical Versus Real Willingness to Pay in the Health Care Sector: Results from a Field ExperimentBlumenschein, K. / Johannesson, M. / Yokoyama, K. / Freeman, P. et al. | 2001
- 80
-
PAR14: Assessment of the Relationship Between Disease Severity, Quality of Life and Willingness to Pay in AsthmaZillich, A. / Blumenschein, K. / Johannesson, M. / Freeman, P. et al. | 2001
- 80
-
PAR16: Cost of Treating Asthma in a Managed Care PopulationArmstrong, E. P. / Malone, D. C. / Rehfeld, R. A. et al. | 2001
- 80
-
PAR15: Comparison of Health Care Resource Utilization of COPD Patients on Cilomilast, 15 mg BID Versus PlaceboBagchi, I. / Bakst, A. / Edelson, J. / Amit, O. et al. | 2001
- 81
-
PAR18: Costs of Treating COPD in Italy: A Burden of Illness StudyBonzanini, A. / Avossa, R. / Scipioni, E. / Gianfrate, F. et al. | 2001
- 81
-
PAR17: Patient Satisfaction with Non-Sedating AntihistaminesSahu, S. / Millard, R. et al. | 2001
- 81
-
PAR19: Impact of the Addition of Salmeterol to the Treatment of Asthma Patients in a Medicaid Fee-for-Service PopulationKlaurens, L. M. / Dodd, M. A. / Gupchup, G. V. / Kelly, H. W. / Hollarbush, J. et al. | 2001
- 82
-
PAR21: Levalbuterol Use is Associated with Decreased Health Care Costs in Patients with More Severe AsthmaHuse, D. / McLoney, A. / Yeager, B. / Cerasoli, F. et al. | 2001
- 82
-
PAR20: Effectiveness of Compliance on Health Care Resource Use in Asthma Patients Treated with Montelukast vs. Inhaled CorticosteroidsKutikova, L. / Bowman, L. / Morris, L. et al. | 2001
- 83
-
PAR22: Impact of Levalbuterol Versus Racemic Albuterol on Outpatient Asthma Care ChargesHuse, D. / McLoney, A. / Yeager, B. / Cerasoli, F. et al. | 2001
- 83
-
PAR23: Determinants of Inappropriate Antibiotic PrescribingWillis, M. K. et al. | 2001
- 84
-
PCN2: Which Variables Do Metastatic Breast Cancer Patients and Oncology Nurses Anchor on When Using the EuroQoL Descriptive System in Measuring Utilities with the Standard Gamble Technique?Hauser, R. / Koeller, J. et al. | 2001
- 84
-
PCN1: Categorization of Risk of Prostate Cancer: Pilot Test of Clinical Outcomes and Risk PerceptionsBruner, D. W. / Parlanti, A. A. / Ross, E. / Raysor, S. / Mazzoni, S. E. / Hanks, G. E. et al. | 2001
- 84
-
PCN3: Predictors of Chemotherapy-Related Neutropenia: A Review of the Clinical LiteraturePalmer, C. / Brown, R. / Wilson-Royalty, M. / Lawless, G. et al. | 2001
- 85
-
PCN5: Docetaxel/Doxorrubicin (DD) as First Line Chemotherapy: Quality of Life (QoL) in Patients (Pts) with Metastatic Breast Cancer (MBC)Bonicatto, S. C. et al. | 2001
- 85
-
PCN4: Comparing Mean Versus Median Survival as a Prelude to Cost-Effectiveness (C/E) AnalysesGagnon, D. D. / Martin, S. C. / van Hout, B. et al. | 2001
- 86
-
PCN8: Economic Evaluation of Gemzar in the Treatment of Pancreatic Cancer in the UKStephenson, D. / Botwood, N. / McKendrick, J. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. et al. | 2001
- 86
-
PCN6: Can ICD-9 Codes Be Used as a Proxy for Disease Staging in Economic Evaluations?Thomas, S. K. / Brooks, S. E. / Mullins, C. D. et al. | 2001
- 86
-
PCN7: Economic Evaluation of Gemzar and Best Supportive Care (BSC) Relative to Best Supportive Care Alone in the Treatment of Non Small Cell Lung (NSCLC) Cancer in the UKMcKendrick, J. / Botwood, N. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 87
-
PCN10: Cost-Effectiveness Model of Prostate-Specific Antigen (PSA) Screening for Prostate CancerSokolskiy, L. / Hay, J. W. et al. | 2001
- 87
-
PCN9: Economic Evaluation of Gemzar/Cisplatin Relative to Other New Agents for Non Small Cell Lung Cancer (NSCLC) in the UKLees, M. / Aristides, M. / Botwood, N. / McKendrick, J. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 88
-
PCN11: Economic Evaluation of Liposomal Doxorubicin vs Topotecan for Recurrent Ovarian Cancer in the UKSmith, D. H. / Drummond, M. F. / Johnston, S. / Gordon, A. et al. | 2001
- 88
-
PCN12: Cost-Utility Analysis Comparing Paclitaxel to Docetaxel in the Treatment of Metastatic Breast CancerHauser, R. / Theriault, R. / Shepherd, M. / Lawson, K. / Wilson, J. / Koeller, J. et al. | 2001
- 88
-
PCN13: Cost of Thrombocytopenia-Related Bleeding Among Patients with CancerElting, L. S. / Martin, C. G. / Hamblin, L. / Chau, Q. et al. | 2001
- 89
-
PCN14: Choice of Localized Breast Cancer Treatments in a Medicare Population: A Comparison of Outcomes and CostsPolsky, D. / Venditti, L. / Mandelblatt, J. S. / Weeks, J. C. / Hadley, J. / Hwang, Y. T. / Schulman, K. et al. | 2001
- 89
-
PCN15: Differences Between Preferences for Health States: The Chemotherapy Adverse Event Self-Assessed Response (CAESAR) QuestionnairePurdum, A. G. / Globe, D. / Mathes, A. / Nichol, M. B. et al. | 2001
- 90
-
PCN16: Chemotherapy Treatment in Newly Diagnosed Breast Cancer Patients in a Managed Care PopulationYazdani, C. / McLaughlin, T. / Koos, F. / Hansen, J. et al. | 2001
- 90
-
PCN17: An Analysis of Resource Use in the Treatment of Advanced Colorectal Cancer in the UKSorensen, S. / Brown, R. / De Cock, E. / Bearne, A. et al. | 2001
- 91
-
PCN20: Cost Minimization Analysis of Cefepime Versus Imipenem-Cilastatine in Cancer Patients with Short-Duration Febrile NeutropeniaVorobjov, P. / Fisenko, V. / Gerasimov, V. / Avxentieva, M. et al. | 2001
- 91
-
PCN18: Colorectal Cancer Screening: Awareness, Utilization, and BarriersStraus, W. / Schaffner, P. / Gold, K. / Pashos, C. / Mansley, E. et al. | 2001
- 91
-
PCN19: Colorectal Cancer Screening Tests: Variation in Preferences Based on Gender and RaceStraus, W. / Schaffner, P. / Gold, K. / Pashos, C. / Mansley, E. et al. | 2001
- 92
-
PCN21: Health-Related Quality of Life After Androgen Deprivation Therapy in Men with Prostate CancerLubeck, D. P. / Grossfeld, G. D. / Carroll, P. R. et al. | 2001
- 92
-
PCN22: Cost-Effectiveness Analysis Comparing Paclitaxel to Docetaxel in the Treatment of Metastatic Breast CancerHauser, R. / Koeller, J. et al. | 2001
- 93
-
PCN23: Disease Modeling: Developing the Infrastructure for a Comprehensive, Multi-National, Clinical and Economic Breast Cancer Treatment ModelBecker, R. V. / Noe, L. / Gore, M. / Martino, S. / Eiermann, W. / Namer, M. / Howell, A. / Bianco, A. / Watanabe, T. et al. | 2001
- 93
-
PCN24: Incidence and Cost of Hospitalization for 5-FU Toxicity Among Medicare Beneficiaries with Metastatic Colorectal CancerDelea, T. E. / Vera-Llonch, M. / Edelsberg, J. S. / McGarry, L. / Anton, S. / Ulcickas-Yood, M. / Oster, G. et al. | 2001
- 93
-
PCN25: A Quality of Life Audit of Patients with Non-Small Cell Lung Cancer Having Chemotherapy at One InstitutionMusgrave, K. R. / Wyld, D. / Abraham, R. et al. | 2001
- 94
-
PCN27: Cost of Treatment for Squamous Cell Carcinoma of the Head and Neck in the United StatesCronin, K. / Lee, B. / Wang, D. et al. | 2001
- 94
-
PCN26: Systematic Assessment of Health-Related Quality of Life Instruments for Use in Clinical Trials of Non-Small Cell Lung CancerHuang, J. C. / Veenstra, D. L. et al. | 2001
- 95
-
PCN28: Detecting Recurrent Papillary or Follicular Thyroid Cancer in Clinical Practice: Need for a Change?Hooft, L. / Hoekstra, O. S. et al. | 2001
- 95
-
PCV2: Venous Thromboembolic (VTE) Complications Following Major Orthopedic Surgery: Frequency and Economic Consequences in HospitalGabriel, S. / Dinet, J. / Dispot, T. / Radal, C. et al. | 2001
- 95
-
PCV1: A Cost-Effectiveness Analysis of Clopidogrel Versus Aspirin as Prevention of Ischemic Events in Patients with Established Peripheral Artery DiseaseDecerbo, M. C. / Baroletti, S. A. / Isopo, S. / Silva, M. / Talati, D. K. et al. | 2001
- 96
-
PCV3: An Analysis of the Cost of Adverse Events Associated with the Use of HMG-CoA Reductase InhibitorsMcBurney, C. R. / Smith, D. et al. | 2001
- 96
-
PCV4: Assessing Quality of Life in Patients Six Months After a Myocardial Infarction Using the SF-12McBurney, C. R. / Erickson, S. R. / Kline-Rogers, E. M. / Cooper, J. V. / Mani, O. C. / Eagle, K. A. et al. | 2001
- 97
-
PCV7: Cost-Utility Analysis of Drug Therapy Options for Intermittent ClaudicationMcGhan, W. F. et al. | 2001
- 97
-
PCV5: Cost of Treatment and Prevalence of Cardiovascular Disease Comorbidities and Risk Factors in the Severe and Persistently Mentally IllBellnier, T. J. / Labrum, A. / Karki, S. D. / Sundberg, J. et al. | 2001
- 97
-
PCV6: Estimating Incremental Costs for Additional Hospital DaysFriedman, J. Y. / Reed, S. D. / Gnanasakthy, A. / Schulman, K. A. et al. | 2001
- 98
-
PCV9: An Economic Analysis of Congestive Heart Failure (CHF) in the Louisiana Medicaid ProgramOgale, S. S. / Blake, S. G. / Biglane, G. C. / Medon, P. J. et al. | 2001
- 98
-
PCV10: Incidence of Rhabdomyolysis in Patients Initiated on HMG Co-A Reductase Inhibitor Therapy in a Managed Care OrganizationWhite, T. J. / Chang, E. Y. et al. | 2001
- 98
-
PCV8: Patient Compliance with Different Prescribed Regimens of Diltiazem in Angina Pectoris: Database Analysis in FranceBaptiste, C. / Guilhaume, C. et al. | 2001
- 99
-
PCV12: Quality of Care in Older Patients Admitted to Hospital with Heart FailureAbdelhafiz, A. H. / Wheeldon, N. et al. | 2001
- 99
-
PCV11: Cost of Warfarin Treatment of Atrial Fibrillation in Clinical PracticeAbdelhafiz, A. H. / Wheeldon, N. et al. | 2001
- 100
-
PCV13: Impact on Quality Adjusted Life Years on Enoxaparin for Preventing Thrombosis Among Hospitalized Medical PatientsRaisch, D. W. / Fye, C. L. / Sather, M. R. / Henderson, W. G. / Reda, D. J. / Sacks, J. M. / Lederle, F. L. et al. | 2001
- 100
-
PCV14: Impact of Obesity on Health-Related Quality of Life (HRQoL): An Analysis of Behavioral Risk Factor Surveillance System (BRFSS) DataHassan, M. / Joshi, A. V. / Madhavan, S. / Amonkar, M. et al. | 2001
- 100
-
PCV15: Economic Evaluation of Outpatient Anticoagulant/Antiplatelet Therapy Following Coronary Stenting in a Managed Care PopulationLiao, E. / Fronk, M. / Newell, J. / Huse, D. et al. | 2001
- 101
-
PCV16: Cost-Effectiveness Analysis of Enoxaparin Versus Unfractionated Heparin in Acute Coronary Syndrome Patients in PolandOrlewska, E. / Budaj, A. / Tereszkowski-Kaminski, D. et al. | 2001
- 101
-
PCV17: Quality of Life and Patient Preference as Predictors for Resource Utilization Among Patients with Heart Failure; Interim AnalysisShin, G. P. / Tooley, J. F. / Southworth, M. R. / Dunlap, S. / Boyer, J. G. / Johnson, N. E. et al. | 2001
- 102
-
PCV20: Assessing the Total Cost of Management of a Patient with Deep Vein Thrombosis (DVT) in France and in ItalyLevy, E. / Gabriel, S. / Dinet, J. / Rudelli, G. et al. | 2001
- 102
-
PCV18: Framingham Risk Equations Predict Hospital Usage and MortalityMilne, R. J. / Gamble, G. D. / Whitlock, G. / Jackson, R. T. et al. | 2001
- 102
-
PCV19: Discriminability for Risk of Cardiovascular EventsMilne, R. J. / Gamble, G. D. / Whitlock, G. / Irwin, R. J. / Jackson, R. T. et al. | 2001
- 103
-
PCV22: In-Patient and Out-Patient Resource Utilization Among Patients with Acute Ischemic Stroke-The VA ExperienceL Italien, G. J. / Williams, L. S. / Weinberger, M. et al. | 2001
- 103
-
PCV21: Cost-Effectiveness Analysis of Abciximab, Eptifibatide, and Tirofiban in Patients with Coronary SyndromesShahriar, J. / Shaw, J. W. / Malone, D. et al. | 2001
- 104
-
PCV24: Beyond the First Year: Patterns and Predictors of Long-Term Statin UtilizationBenner, J. S. / Federman, A. D. / Smitten, A. L. / Duty, S. / Glynn, R. J. / Avorn, J. et al. | 2001
- 104
-
PCV23: Pharmacoeconomic Evaluation of Usage of Unfractionated Heparin and Low Molecular Weight Heparin in the Treatment of Deep Vein Thrombosis in Long-Term Care ResidentsKarki, S. D. / Bellnier, T. J. / Karki, J. / Patterson, W. / Masood, R. et al. | 2001
- 104
-
PCV25: CHD Risk Factors and Therapy Duration of HMG-CoA Reductase Inhibitors (Statins) in a Medicaid PopulationNichol, M. B. / Bron, M. S. / Yu, W. et al. | 2001
- 105
-
PCV28: Cholesterol Reduction Success Rates and Resource Utilization by GenderGraff, J. S. / Plante, M. / Smith, D. et al. | 2001
- 105
-
PCV26: Caring for Hypertension on Initiation: Costs and Effectiveness (CHOICE). Design and Rationale of a Naturalistic StudyPayne, K. / Caro, J. / Hollenberg, N. / Jackson, J. / L Italien, G. / CHOICE Study Group et al. | 2001
- 105
-
PCV27: A Pharmacoeconomic Model to Evaluate Treatment Options for DVT PharmacoprophylaxisSpruill, W. J. / Wade, W. E. / Leslie, R. B. et al. | 2001
- 106
-
PCV29: Economic Outcomes of Patients Receiving Carvedilol Compared to Those Receiving No Beta-Blocker Therapy for the Treatment of Congestive Heart Failure in a Managed Care OrganizationWhite, T. J. / Chang, E. Y. / Leslie, R. S. / Jackson, A. J. et al. | 2001
- 106
-
PCV30: Cost-Effectiveness Model of Thrombolytic Therapy for Acute Myocardial InfarctionMulani, P. / Hay, J. et al. | 2001
- 107
-
PCV31: Closure of Atrial Septal Defect: Medico-Economic Arguments to Choose Between Invasive Surgery and Percutaneous Technique Using Septal OccluderLaroche, S. / Allenet, B. / Foroni, L. / Calop, J. et al. | 2001
- 107
-
PCV32: Strategies for Improving Compliance with HMG-CoA Reductase InhibitorsCoombs, J. H. / Cornish, L. / Hiller, P. / Smith, D. G. et al. | 2001
- 107
-
PCV33: Cost-Analysis of CABG Surgery in Patients with and without Rethoracotomy from the Hospital Perspective in GermanySpannheimer, A. / Mast, O. / Schlereth, T. / Thate-Waschke, I. M. / Dietrich, W. et al. | 2001
- 108
-
PCV34: Decision Analysis Model of Abciximab, Eptifibatide or Standard Therapy in Elective Stent Placement: A Canadian PerspectiveSridhar, K. / Gwadry, F. / Kidwai, B. / Almond, D. / Teefy, P. et al. | 2001
- 108
-
PCV35: Comparability of Published Studies on Cost-Effectiveness of Antihypertensive Therapy: Do the Results Help the Decision-Making Process?Mullins, C. D. / Akhras, K. S. / Blak, B. et al. | 2001
- 109
-
PCV36: Evaluation of Compliance and Persistence with HMG-CoA Reductase Inhibitors After a Myocardial Infarction Using Pharmacy Claims DataCoombs, J. H. / Cornish, L. / Hiller, P. / Smith, D. G. et al. | 2001
- 109
-
PCV37: The Cost-Effectiveness of Statins: Evidence from the ACCESS TrialSmith, D. G. et al. | 2001
- 110
-
PCV40: Cost-Effectiveness of Lipid Lowering Interventions in a Native American Cardiovascular Risk Reduction ProgramKumar, R. N. / Borrego, M. E. / Gupchup, G. V. / Anderson, J. R. / Burden, R. W. / Phillips, D. L. et al. | 2001
- 110
-
PCV38: Withdrawn| 2001
- 110
-
PCV39: Cost of Treatment of Hypercholesterolaemia to NHF Goals in AustraliaWlodarczyk, J. / Barter, P. j. / O Brien, R. / Talmont, D. / Ortiz, M. et al. | 2001
- 111
-
PCV42: Patients' Willingness to Pay for Pharmacist Managed Warfarin Therapy at Community PharmaciesWong, P. K. / Jang, R. et al. | 2001
- 111
-
PCV41: Socioeconomic Relevance of Treatment of Chronic Heart Failure Stage NYHA II With Crataegus Extract WS 1442-One-Year Results of a Prospective Pharmacoeconomic StudyPfeil, T. / Rychlik, R. / Daniel, D. / Habs, M. / Klapper, H. G. / Bohm, M. et al. | 2001
- 112
-
PDB1: Diabetic Management Through Oral Glucose Lowering Agents: Treatment Pattern, Cost and Utilization AnalysisThompson, F. D. / Rosenblum, M. S. / O Neill, J. M. / Celebi, D. / Olmsted, E. et al. | 2001
- 112
-
PDB2: Using Retrospective Claims Data to Design Clinical Safety Surveillance of Thiazolidinedione DrugsHenriques, C. / Schultz, D. / Milanette, T. / Todoroff, K. / Kim, M. et al. | 2001
- 113
-
PDB3: The Burden of Illness of Diabetes Mellitus Type 2 in Germany-A Pilot StudyTepe, M. / Kilburg, A. / Daniel, D. / Kirchhoff, D. / Rychlik, R. et al. | 2001
- 113
-
PDB4: Cost-Effectiveness and Cardiovascular Risk-An Analysis of Rosiglitazone Compared with other Oral Hypoglycemic Agents in the Treatment of Type 2 Diabetes MellitusOh, P. I. / Shane, L. G. et al. | 2001
- 114
-
PDB7: Costs and Effectiveness of Intensive Insulin Therapy for Type 2 DiabetesHisashige, A. / Katayama, T. / Mikasa, H. et al. | 2001
- 114
-
PDB5: A Cost-Minimization Study to Determine the Impact of Adding Glucovance to a County Hospital FormularyLal, L. S. / Ogbonnaya, K. I. et al. | 2001
- 114
-
PDB6: An Early Look at TZD Use Among Type 2 Diabetes PatientsSchabert, V. F. / Guo, M. / Conklin, J. E. / Neslusan, C. A. et al. | 2001
- 115
-
PDB10: The Cost of New Onset Diabetes Mellitus Among US Renal Transplant RecipientsWoodward, R. S. / Schnitzler, M. A. / Lowell, J. A. / Haider, S. / Brennan, D. C. et al. | 2001
- 115
-
PDB8: Factors Associated with Prescription Claims for Blood Glucose Test Strips Among Fee-for-Service New Mexico Medicaid PatientsCordova, C. J. / Shah, B. M. / Dodd, M. A. / Gupchup, G. V. et al. | 2001
- 115
-
PDB9: Cost-Effectiveness Analysis of a Multidisciplinary Diabetes Care ClinicYokoyama, K. K. / Griffin, K. C. / Godley, P. J. / Cryar, A. K. / Woodward, B. W. et al. | 2001
- 116
-
PDB13: Optimization of Diabetes Management in Germany Using a Computer Based Outcome Prognoses ModelBrandt, A. / Gozzoli, V. / Palmer, A. / Weiss, C. / Neeser, K. / Schramm, W. et al. | 2001
- 116
-
PDB11: Economic Outcomes of Diabetes Among an Employed PopulationLeong, S. A. / Summers, K. H. / Birnbaum, H. G. / Kemner, J. E. / Lentz, E. C. / Greenberg, P. E. et al. | 2001
- 116
-
PDB12: A Pharmacoeconomic Analysis of Weight-Reduction Therapy in a Hypothetical Cohort of Obese Chinese Patients with Impaired Glucose ToleranceLee, K. K. / You, J. H. / Ho, S. S. / Leung, W. Y. / Thomas, G. / Chan, T. Y. / Critchley, J. et al. | 2001
- 117
-
PDB14: Impact of a Diabetes Disease Management Program: A Retrospective Claims-Based EvaluationBerger, J. / Slezak, J. / O Leary, W. / McStay, P. / Johnson, K. / Addiego, J. et al. | 2001
- 117
-
PDB15: Does Patient Experience Matter? Type II Diabetes Patients' Stated Preferences for Insulin TherapiesSmith, G. / Bingham, M. / Johnson, F. R. / Bolinder, B. et al. | 2001
- 118
-
PEE2: The Cost-Effectiveness of Genetic Testing for Periodontal Disease. A Payer's PerspectiveHigashi, M. K. / Veenstra, D. / del Aguila, M. / Hujoel, P. et al. | 2001
- 118
-
PEE1: Antibiotic Prescribing Patterns for the Treatment of Initial Acute Otitis Media in Children Enrolled in Iowa Medicaid from 1990 Through 1997Park, T. R. / Brooks, J. M. et al. | 2001
- 118
-
PDB16: An Overview of Pharmacoeconomics in Turkey: Cost Analysis and Reimbursement of Antidiabetic DrugsSapci, A. H. / Sapci, H. A. / Demirdamar, R. et al. | 2001
- 119
-
PEE4: The French Version of the Psoriasis Disability IndexFinlay, A. / Corvest, M. / Lefrancois, P. / Taieb, C. et al. | 2001
- 119
-
PEE5: Inappropriate Antibiotic Prescribing and Economic Outcomes for Pediatric Otitis MediaRahman, A. M. / Feldhaus, J. / Lawrence, L. / Rappaport, H. / Moser, E. et al. | 2001
- 119
-
PEE3: Dry-Eye Related Increases in Health Care Utilization and ExpendituresSmeeding, J. E. / McLaughlin, T. / Yazdani, C. / Walt, J. G. et al. | 2001
- 120
-
PEE6: Cost-Effectiveness of Artificial Skin Substitute vs Allograft for Burn PatientsBron, M. S. / Hay, J. et al. | 2001
- 120
-
PEE7: A Cost Comparison Study of Common Practice and Best Practice Treatment for Primary Open-Angle Glaucoma in the United StatesEvans, S. J. / Casciano, J. / Doyle, J. J. / Walt, J. G. et al. | 2001
- 121
-
PGI1: Effects on Health Care Contacts and Days Absent from Work with Budesonide CIR Capsules in the Maintenance Treatment of Crohn's Disease in a US SettingEricsson, K. / Borg, S. et al. | 2001
- 121
-
PEE8: Four Year Cost-Effectiveness of Initial Trabeculectomy Versus Conventional Therapy in Primary Open-Angle Glaucoma (POAG)Yu, E. / Hay, J. / Varma, R. / Globe, D. et al. | 2001
- 121
-
PGI2: Alternative Management Strategies for DyspepsiaWu, E. Q. / Hay, J. et al. | 2001
- 122
-
PGI3: A Prospective, Randomized Cost Analysis of Meperidine and Midazolam Versus Propofol for Complex Upper Endoscopy ProceduresShermock, K. M. / Vargo, J. J. / Zuccaro, G. / Maurer, W. G. et al. | 2001
- 122
-
PGI4: Health-Related Quality of Life (HRQoL) Data Reveal Differences Among Clinical "Responders"Watson, M. E. / Heath, A. T. / Northcutt, A. R. et al. | 2001
- 123
-
PGI6: Cost-Effectiveness Analysis of Helicobacter pylori Eradication Triple Therapy Versus Conventional Therapy for Gastric and Duodenal Ulcers in JapanIkeda, S. / Tamamuro, T. / Asaka, M. et al. | 2001
- 123
-
PGI7: Budesonide CIR is Cost-Effective in Maintenance Therapy of Crohn's Disease in FinlandEricsson, K. / Karvonen, A. L. / Sintonen, H. / Borg, S. et al. | 2001
- 123
-
PGI5: Health Care Cost Savings with Budesonide Controlled Ileal Release Capsules (CIR) in Crohn's DiseaseEricsson, K. / Lofberg, R. / Danielsson, A. / Floren, C. H. / Borg, S. et al. | 2001
- 124
-
PGI9: Cost-Effectiveness of `Test&Treat' in Helicobacter pylori Infected Dyspeptic Patients in a Primary Care SettingChen, K. S. / Hay, J. et al. | 2001
- 124
-
PGI8: Rapid Impact of Rabeprazole on Symptom Distress Among Patients with Gastroesophageal Reflux DiseaseDamiano, A. / Adler, E. / Siddique, R. / Sloan, S. / Bhattacharjya, A. et al. | 2001
- 125
-
PGI10: Irritable Bowel Syndrome Costs Sickness Funds DM 2.8 Billion Per YearSchultes, H. J. / Guminski, W. / Rosche, U. / Ries, B. / Pirk, O. et al. | 2001
- 125
-
PGI12: Estimating Potential Utilization of Esomeprazole by Assessing GERD Symptom Control on Traditional PPI'sDeLattre, M. L. / Schaefer, M. / Morreale, A. P. / Plowman, B. K. et al. | 2001
- 125
-
PGI11: Characterization and Markov Modeling of Gastroesophageal Reflux Disease States in a Large Health Care PlanBrelje, T. / Heaton, A. / Martin, S. / Bhattacharjya, A. / Dodd, S. / Thornhill, J. et al. | 2001
- 126
-
PGI14: How Important is Appropriate Empirical Antibiotic Treatment for Intra-Abdominal Infections?Davey, P. / Libby, G. / Hunter, K. / Broomhall, J. / Kofteridis, D. / Steinke, D. / Taylor, E. / Yin, D. et al. | 2001
- 126
-
PGI13: Factors Associated with Physician Knowledge of Whether Prescription Drugs Are on FormularyShih, Y. C. / Sleath, B. et al. | 2001
- 127
-
PGI17: Comparison of Generic Versus Disease Specific Tools for the Measurement of Health-Related Quality of Life in Crohn's DiseaseWurtzbacher, J. D. / Gourley, G. K. / Reed, P. J. / Gourley, D. R. / Solomon, D. K. / Haas, J. W. et al. | 2001
- 127
-
PGI15: Computerized Assessment of Complications Following Colorectal SurgeryKroch, E. / Azimuddin, K. / Rosen, L. / Reed, J. F. et al. | 2001
- 127
-
PGI16: Analysis of the Long-Term Costs, Savings and Effects Generated by Infliximab to Normalize Quality of Life in Patients with Crohn's DiseaseAnnemans, L. / Moeremans, K. / Rutgeerts, P. / Lemmens, L. et al. | 2001
- 128
-
PID2: Impact of Cytomegalovirus (CMV)-Related Readmission on Post Heart Transplant Resource UseLeader, S. / Henderson, R. / Carlin, D. et al. | 2001
- 128
-
PID1: Efficacy of Zinc Lozenges on the Duration of Common Cold Symptoms: A Meta-Analysis RevisitedChaiyakunapruk, N. / Veenstra, D. L. / Sullivan, S. D. / Saint, S. / Bent, S. et al. | 2001
- 129
-
PID4: Economic Cost of HIV Infection in Untreated Workers: An Employer's PerspectiveChaikledkaew, U. / Liu, G. G. / Lyu, R. / Louie, S. et al. | 2001
- 129
-
PID3: Trends in Inpatient Costs for Acute Pancreatitis in the United StatesBell, C. F. / Stephens, J. M. / Botteman, M. F. / Pashos, C. L. / Ewing, M. et al. | 2001
- 129
-
PID5: Moxifloxacin vs Amoxicillin/Clavulanate in the Treatment of Acute Maxillary Sinusitis (AMS): Efficacy, Safety and Patient-Reported Outcomes in Primary CareRakkar, S. et al. | 2001
- 130
-
PID6: HIV/AIDS Health State Utilities Using Community and Patient Preference Weights: When Does It Matter?Schackman, B. R. / Goldie, S. J. / Freedberg, K. A. / Losina, E. / Brazier, J. / Weinstein, M. C. et al. | 2001
- 130
-
PID7: Observational Evaluation of Health State Utilities Among a Cohort of Sepsis PatientsDrabinski, A. / Williams, G. / Formica, C. et al. | 2001
- 131
-
PID8: Costs of Health Care for Hepatitis C-Infected Members in a Managed Care Organization (MCO)Schaffer, M. / Phillips, A. L. / Mansukani, S. et al. | 2001
- 131
-
PID9: Cost-Effectiveness of Interferon Alfa Therapy for Chronic Hepatitis C with CirrhosisHisashige, A. / Katayama, T. / Mikasa, H. et al. | 2001
- 131
-
PID10: Effects of Linezolid on Hospital Length of Stay in Methicillin-Resistant Staphylococcus Infections Estimated from Multivariate Survival AnalysisWillke, R. J. / Li, Z. J. / Glick, H. / Rittenhouse, B. E. / Hafkin, B. et al. | 2001
- 132
-
PID12: Averting Future AIDS Cases: Modeling Costs of Interventions with Out-of-Treatment Substance AbusersRichter, A. / Loomis, B. R. / Wechsberg, W. M. et al. | 2001
- 132
-
PID11: Pegylated (40KDa) Interferon Alfa-2a (PEGASYS®) Significantly Improves Tolerability, Quality of Life, and Work Productivity in Patients With Chronic Hepatitis CImperial, J. / Thuluvath, P. / Perrillo, R. P. / Rothstein, K. D. / Poulios, N. S. / Pappas, S. C. / Ackermann, S. P. / Doerschuk, B. S. et al. | 2001
- 133
-
PID14: Predictors of the Mental (MHS) and Physical Health Summary (PHS) Scores of the MOS-HIV in a Sample of HIV-Infected PatientsGriffis, D. L. / Delate, T. / Coons, S. J. et al. | 2001
- 133
-
PID13: Economic Evaluation of Rotavirus Vaccination for The NetherlandsWelte, R. / Jager, J. / van Duynhoven, Y. / de Wit, M. et al. | 2001
- 133
-
PID15: Managing AIDS in the Era of Antiretroviral Therapy: Changes in the Rate and Cost of HospitalizationsO Brien, J. A. / Pierce, D. / Patrick, A. R. / Caro, J. J. et al. | 2001
- 134
-
PID18: Methicillin-Resistant Staphylococcus Species Treatment Patterns in CanadaBecker, D. / Rosner, A. J. et al. | 2001
- 134
-
PID16: Cost Burden of Varicella-Zoster Virus Infection in a Managed Care SettingSchaffer, M. / Liu, M. / Scott, W. / Mansukani, S. et al. | 2001
- 134
-
PID17: Economic Evaluation of Oseltamivir for Influenza Patients in JapanKobayashi, M. et al. | 2001
- 135
-
PID19: An Economic Analysis of Cefdinir Versus Loracarbef for Treatment of Acute Exacerbations of Chronic BronchitisShah, S. N. / Smith, D. / Copley-Merriman, C. et al. | 2001
- 135
-
PID20: Targeting Populations At-Risk for Urinary Tract Infection ComplicationDoyle, B. / Hess, G. et al. | 2001
- 136
-
PID21: The Cost-Effectiveness Analysis of Lamivudine in the Treatment of Chronic Hepatitis B in PolandOrlewska, E. et al. | 2001
- 136
-
PID23: Patterns of Antibiotic Use and Costs Associated with Episodes of Treatment for Common Outpatient Respiratory-Tract Infections: An Analysis of Managed-Care DataEdelman-Lewis, B. / Menzin, J. / Boulanger, L. / Leung, M. / Friedman, M. / Hurley, J. S. / Harnett, J. / Wilson, J. et al. | 2001
- 136
-
PID22: An Appraisal of Health-Related Quality of Life Instruments for Use in Patients Diagnosed with Human Immunodeficiency Virus (HIV) DiseaseJoshi, A. V. / Nau, D. P. / Kalsekar, I. D. et al. | 2001
- 137
-
PID25: Economic Evaluation of Macrolides and Fluoroquinolones for the Treatment of Respiratory Tract InfectionsLachaine, J. / Laurier, C. / Manzi, P. et al. | 2001
- 137
-
PID24: Cost Comparison of Gatifloxacin Versus Levofloxacin in the Treatment of Community-Acquired Pneumonia in an Outpatient PopulationBell, T. J. / Loomis, B. R. / Mauskopf, J. A. / L Italien, G. J. / Gallagher, K. M. et al. | 2001
- 138
-
PID27: Does a Day Still Make a Difference? A Decision Analysis of Adult Streptococcal PharyngitisRousculp, M. D. et al. | 2001
- 138
-
PID28: Comparing Differences in Clinical Effectiveness, Nephrotoxicity, and Cost-Effectiveness of Aminoglycoside Therapy Between Alternative Dosing ProtocolsReynolds, R. / Gupchup, G. / Borrego, M. / Raisch, D. / Netravali, S. et al. | 2001
- 138
-
PID26: Pharmacoeconomic Evaluation of Cefuroxime in Abdominal HysterectomyKarpov, O. / Zaytsev, A. et al. | 2001
- 139
-
PMH2: Treatment Course and Charges for Depressed Patients Treated with Sertraline, Venlafaxine, and Venlafaxine XR in the Managed Care SettingHirschfeld, R. / Eaddy, M. / Grudzinski, A. et al. | 2001
- 139
-
PMH1: Should the 51 Items of the Schizophrenia Outcomes Assessment Project (SOAP-51) Be Weighted?Barr, J. / Schumacher, G. / Mason, E. / Ohman, S. / Goren, J. / Hanson, A. et al. | 2001
- 140
-
PMH5: From First to Second: Impact of Participant Characteristics on the Time to First Switch in a Schizophrenia PopulationRusso, P. / Vasey, J. et al. | 2001
- 140
-
PMH3: Is Depression the Major Cause of Impaired Quality of Life in Schizophrenic Patients?Toumi, M. / Pettersson, A. / Llorca, P. M. / Lancon, C. / Aballea, S. et al. | 2001
- 140
-
PMH4: Assessment of Patients' Attitudes Toward Antipsychotic Treatment in a 40-Week Randomized, Controlled TrialDugar, A. / Stuelpner, J. E. / Mackell, J. A. / Miceli, R. J. et al. | 2001
- 141
-
PMH7: Change in Maladaptive Behaviors Associated with Antidepressants in Older Depressed PatientsJensik, S. E. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Edell, W. S. / Adams, B. E. et al. | 2001
- 141
-
PMH6: Change in Instrumental Activities of Daily Living Associated with Antidepressants in Older Depressed PatientsEdell, W. S. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Adams, B. E. / Jensik, S. E. et al. | 2001
- 142
-
PMH9: Health Care Utilization and Costs in Schizophrenic Patients Taking Risperidone Versus Olanzapine in a Veterans Administration PopulationShermock, K. M. / Fuller, M. A. / Secic, M. / Laich, J. S. / Durkin, M. B. et al. | 2001
- 142
-
PMH10: Health Outcomes of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): Health Care Use and Work Status of CaregiversNoe, L. / Hankin, C. S. et al. | 2001
- 142
-
PMH8: Impact of Current Antidepressants on Cognition in Older Patients with DepressionAdams, B. E. / Mayo, K. W. / Sandoval, R. I. / Bailey, K. L. / Jensik, S. E. / Edell, W. S. et al. | 2001
- 143
-
PMH12: Prevalence of Comorbid Anxiety and Depression Among Patients Prescribed SSRI MonotherapyGrotzinger, K. M. / Chang, L. L. et al. | 2001
- 143
-
PMH11: Schizophrenia Care and Assessment Program (SCAP): The Impact of Clinical Syndrome, Antipsychotic Medication Treatment and Adherence on Outpatient Psychiatric UtilizationRusso, P. / Smith, M. et al. | 2001
- 144
-
PMH14: Deficit Syndrome and Drug Use Patterns in a Community-Based Schizophrenia CareRusso, P. / Kirkpatrick, B. et al. | 2001
- 144
-
PMH15: A Retrospective Economic Evaluation of Olanzapine Versus Risperidone in the Treatment of SchizophreniaZhao, Z. et al. | 2001
- 144
-
PMH13: Pre-Treatment Patient Differences: Choice of Drug Therapy Within SchizophreniaGibson, P. J. / Loosbrock, D. L. et al. | 2001
- 145
-
PMH16: Use of Rasch Models for Validation of Instruments Used in Mental Health EvaluationLancon, C. / Toumi, M. / Pettersson, A. / Aballea, S. / Fournier, A. et al. | 2001
- 145
-
PMH17: Typical and Atypical Antipsychotics in the Treatment of Schizophrenia: Assessment of Clinical And Economic Outcomes Using a Markov ModelNeeser, K. / Schramm, W. / Brandt, A. / Hoffler, J. / Jurgens, T. / Mast, O. et al. | 2001
- 146
-
PMH18: Health Care Utilization in Patients with Treatment Resistant DepressionCrown, W. H. / Ling, D. C. / Finkelstein, S. N. / Berndt, E. R. / White, A. S. et al. | 2001
- 146
-
PMH20: Dosing of Benzodiazepine Hypnotics in Elderly PatientsYoung, J. K. / Schultz, D. / Foster, D. / Heller, S. et al. | 2001
- 146
-
PMH19: Risk of Hospitalization for Patients with Bipolar DisorderLing, D. C. / Bresnahan, B. W. / White, A. S. / Neslusan, C. A. / Crown, W. H. et al. | 2001
- 147
-
PMH22: Patterns of Antidepressant Use and Health Care Costs in Depressed Patients Who Received SSRI TherapyWade, S. W. / Berzon, R. / Patton, M. P. / Koch, P. / Batra, D. et al. | 2001
- 147
-
PMH21: Quality of Life of Non-Institutional Caregivers of Schizophrenic Patients: Contribution of Qualitative Interviews to Questionnaire GenerationAuquier, P. / Simeoni, M. C. / Azorin, J. M. / Lancon, C. / Toumi, M. et al. | 2001
- 148
-
PMH24: The Cost of Acute Hospitalization for Anorexia Nervosa and BulimiaO Brien, J. A. / Patrick, A. R. et al. | 2001
- 148
-
PMH23: Deinstitutionalization of Schizophrenic Patients: Cost-Consequences and Policy Implication of Intensive Case Management Versus Standard Case ManagementLlorca, P. M. / Toumi, M. / Hansen, K. / Barre, S. / Francois, C. et al. | 2001
- 148
-
PMH25: A Model Comparing Olanzapine and Ziprasidone in Patients with SchizophreniaAlexeyeva, I. / Mauskopf, J. / Earnshaw, S. / Gibson, P. J. / Ascher-Svanum, H. / Ramsey, J. L. et al. | 2001
- 149
-
PMH26: Outpatient Antipsychotic Use: Comparing Atypical and Conventional Antipsychotic Adherence Using a National Retail Pharmacy Data BaseVanelli, M. R. et al. | 2001
- 149
-
PMH28: Depression and Homelessness, a French InitiativeEmmanuelli, X. / Hassin, J. / Smadja, C. / Taieb, C. et al. | 2001
- 149
-
PMH27: Cost-Utility Analysis of Quetiapine Compared to Risperidone in the Treatment of Patients with Schizophrenia or Other Psychotic DisordersSimons, W. R. / Meddis, D. et al. | 2001
- 150
-
PMH29: Cost Analysis of Olanzapine Versus Risperidone in the Treatment of Uncontrolled SchizophreniaZhao, Z. et al. | 2001
- 150
-
PMH30: Differences in Health Care Expenditures Among Patients Treated for Depression with or without AnxietyCrown, W. / Wan, G. J. / Berndt, E. R. / Finkelstein, S. N. / Ling, D. et al. | 2001
- 151
-
PMH31: Pharmacoeconomic Evaluation of the Treatment with Olanzapine in "Revolving Door" Schizophrenic PatientsGurovich, I. / Lyubov, E. / Shmukler, A. et al. | 2001
- 151
-
PMH32: Barriers to the Use of Medications to Treat AlcoholismMark, T. L. / Kranzler, H. R. / Poole, V. H. / Hagen, C. A. / McLeod, C. / Crosse, S. E. et al. | 2001
- 151
-
PMH33: Olanzapine Versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs Among Texas Medicaid PatientsRascati, K. L. / Johnsrud, M. / Crismon, M. L. / Barber, B. L. / Lage, M. J. et al. | 2001
- 152
-
PMH34: Switching and Augmentation of Antidepressants in Older Depressed PatientsAdams, B. E. / Jensik, S. E. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Edell, W. S. et al. | 2001
- 152
-
PMH35: Patterns of Antidepressant and Antipsychotic Medication Use in Medicaid, 1995-1999Gregorian, R. / Gemmen, E. et al. | 2001
- 153
-
PPN1: An Internet Study of WTP for Migraine PharmacotherapiesLenert, L. A. / Minh, C. / Jackson, C. et al. | 2001
- 153
-
PMH36: Dosing of Benzodiazepine Hypnotics in Elderly PatientsYoung, J. K. / Schultz, D. / Foster, D. / Heller, S. et al. | 2001
- 153
-
PPN2: Use of Galantamine in The Netherlands for the Treatment of Mild to Moderate Alzheimer's DiseaseCard, J. / Salas, M. / Getsios, D. / Mehnert, A. / AHEAD Study Group et al. | 2001
- 154
-
PPN3: The Impact of Dementia on Caregiver Quality of LifeGold, K. F. / Botteman, M. F. / Kemp, R. / Kittner, B. / Pashos, C. L. et al. | 2001
- 154
-
PPN4: Utility Assessments of Opioid Treatment in the US, Canada and Australia for Patients with Chronic Non-Malignant PainSchmier, J. / Palmer, C. / Ingham, M. / Mathur, S. / Dodd, S. / Gourlay, G. et al. | 2001
- 155
-
PPN6: Validation of the 24 Hour Headache Disability Questionnaire (DISQ-24) in a Sample of Headache SufferersRunken, M. C. / Kwong, W. / Davis, K. / Batenhorst, A. et al. | 2001
- 155
-
PPN7: A Model for Predicting the Incidence of Migraine in the Idaho Medicaid PopulationShaw, J. / Joish, V. / Cady, P. S. et al. | 2001
- 155
-
PPN5: Comparison of Costs and Cost-Effectiveness of Oxcarbazepine and Sodium Valproate for New/Recent Onset Partial SeizuresBazalo, G. / Sachdeo, R. / Graham, S. / Chang, S. / Cohen, A. et al. | 2001
- 156
-
PPN8: Psychometric Evaluation of Widely Used Pain Measures for Purpose of Computerized Dynamic Pain AssessmentZhao, J. H. / Ware, J. E. / Kosinski, M. / Bjorner, J. B. / Turner-Bowker, D. et al. | 2001
- 156
-
PPN9: How is Pain Felt Across Countries? The Short-Form McGill Pain Questionnaire (SF-MPQ) in 10 LanguagesConway, K. / Uzun, V. / Alacoque, J. / Abetz, L. / Melzack, R. / Plante, M. et al. | 2001
- 157
-
PPN11: The Migraine in France in 2000: Epidemiological DataHenry, P. / Auray, J. P. / Duru, G. / Chazot, G. / Dartigues, J. F. / Lanteri-Minet, M. / Lucas, C. / Pradalier, A. / El Hasnaoui, A. / Gaudin, A. F. et al. | 2001
- 157
-
PPN10: Survival and Nursing Home Free Survival (NHFS) of AD PatientsWu, E. Q. / Hay, J. et al. | 2001
- 157
-
PPN12: Differences in Health-Related Quality of Life Between Migraineurs with and without Prophylactic Medication UseGirts, T. K. / Lofland, J. H. / O Connor, J. P. et al. | 2001
- 158
-
PPN13: Delays in Nursing Home Placement for Patients with Alzheimer's Disease Associated with Treatment with Donepezil May Have Health Care Cost-Saving ImplicationsProvenzano, G. / Duttagupta, S. / McRae, T. / Mastey, V. / Ellis, B. / Ieni, J. et al. | 2001
- 158
-
PPN14: A Prognostic Model to Predict Quality of Life Chances After Subarachnoid HemorrhageToth, K. / Szende, A. / Contreraz, M. / Machovich, A. / Futo, J. / Nyari, I. et al. | 2001
- 159
-
PPN17: Addressing Paradoxes in Economic Evaluations (EES). An Example Using Motor Neuron Disease (MND)Bose, U. K. / Burrell, A. / Ward, J. et al. | 2001
- 159
-
PPN16: Economic Burden and Loss in Quality of Life Due to Low Back PainSzende, A. / Lovas, K. / Szebenyi, B. / Balint, G. / Hejj, G. et al. | 2001
- 159
-
PPN15: Multiple Pain Relief Assessment in Women Undergoing Natural Versus Epidural Delivery with Ropivacain or BupivacainSzende, A. / Kincses, Z. S. / Zimanyi, M. / Kadar, Z. / Zorenyi, G. et al. | 2001
- 160
-
PPN18: Cost Savings in Migraine Associated with Less Chest Pain on New Triptan TherapyWang, J. T. / Barr, C. E. / Torigoe, Y. / Wang, E. I. / Rowland, C. R. / Goldfarb, S. D. et al. | 2001
- 160
-
PPN19: Comparison of HUI2 and HUI3 Scores for Patients with Alzheimer's DiseaseNiwata, S. / Yamada, Y. / Ikeda, S. / Ikegami, N. et al. | 2001
- 160
-
PPN20: Estimated Resource Use and Cost of Mitoxantrone vs Placebo in Patients with Progressive-Relapsing and Secondary-Progressive Multiple Sclerosis: Results from the MIMS TrialDurgin, T. L. / Wanke, L. A. / Goodkin, D. / Ghalie, R. et al. | 2001
- 170
-
PHP5: Polish Guidelines for Conducting Pharmacoeconomic Evaluations in Comparison to International Health Economic GuidelinesOrlewska, E. / Mierzejewski, P. et al. | 2001
- 170
-
PHP6: Activities, Functions and Structure of Pharmacy and Therapeutics Committees in Israeli HospitalsRotem, R. / Reuveni, H. / Goldberg, A. et al. | 2001
- 170
-
PHP7: Application of Health Economics in the Canadian Pharmaceutical IndustryHirji, Z. / Rindress, D. E. / Welner, S. A. et al. | 2001
- 171
-
PHP8: Practice Use of Pharmacoeconomics Data in Hospital Formulary DecisionsOdedina, F. T. / Sullivan, J. L. / Nash, R. / Clemmons, C. D. et al. | 2001
- 171
-
PHP10: The Potential Benefits and Drawbacks of Allowing Direct-to-Consumer Advertising of Pharmaceuticals in EuropeDickson, A. J. et al. | 2001
- 171
-
PHP9: Comparison of Technology Assessment in Large Medical Groups and Health Maintenance Organizations (HMOS)Wise, S. / Donohue, T. F. et al. | 2001
- 172
-
PHP11: Use of the Andersen Health Care Services Utilization Behavioral Model to Understand the Relationship Between Health Insurance Coverage and Health Care Services Utilization Among the ElderlyYang, M. / Barner, J. C. et al. | 2001
- 172
-
PHP12: Acute Care Elderly Units: Their Prevalence, Characteristics and DeterminantsJayadevappa, R. / Raziano, D. B. / Samakur, M. / Lavizzo-Mourey, R. et al. | 2001
- 173
-
PHP13: Indices for Evaluation of Drug Cost/Utilization: Every Silver Lining Has a Gray CloudValuck, R. J. et al. | 2001
- 173
-
PHP14: Cost Analysis of Pharmaceutical Services in a Teaching InstitutionBussieres, J. F. / Lebel, D. et al. | 2001
- 174
-
PHP17: Patient Outcomes in the Sedated ICU PatientKamath, T. / Hopefl, A. / Chaikledkaew, U. / Johnson, K. A. et al. | 2001
- 174
-
PHP15: A Survey of Public Hospital Pharmacists in Singapore on Their Views About the `Formulary' and Its Decision-Making ProcessRoy, A. / Li, S. C. et al. | 2001
- 174
-
PHP16: The Value of Various Forms of Evidence in Drug Formulary Decision MakingMorris, L. / Aikin, K. et al. | 2001
- 175
-
PHP18: A Model for Comparing Costs Associated with Prescription Wastage with Application to VA Prescription DataWalton, S. M. / Johnson, N. E. / Arondekar, B. V. / Schumock, G. T. et al. | 2001
- 175
-
PHP19: Using Financial Ratios to Compare Pharmacy Spending in the Department of Veterans AffiarsSampson, J. M. et al. | 2001
- 175
-
PHP20: The Lag Between Effectiveness and Cost-Effectiveness Evidence of New Drugs and Decision-Making in Health CareStoykova, B. A. / Drummond, M. / Kleijnen, J. et al. | 2001
- 176
-
PHP23: Drug Reimbursement Program for Indigent Patients: An Economic Impact on the Hospital Administration BudgetNguyen, A. B. / Arbuckle, R. / Anderson, R. W. / Sansgiry, S. S. et al. | 2001
- 176
-
PHP22: Patient Adherence to Drug Therapy in a Three-Tier Copayment StructureHutchison, S. et al. | 2001
- 176
-
PHP21: Single European-Level Cost-Effectiveness Analysis: Over the Fourth Hurdle and into the Ditch?Hutton, J. / Nuijten, M. / Chambers, M. et al. | 2001
- 177
-
PQP1: Lessons Learned from Developing a Psychometrically Based Sedation Questionnaire in Pharmacologically Paralyzed Critically Ill PatientsKane, S. L. / Dasta, J. F. / Pathak, D. S. et al. | 2001
- 177
-
PQP2: Role of Health-Related Quality of Life Outcomes in the European Drug Regulatory Process: A Review of the EMEA DocumentsAcquadro, C. / Staniek, V. / ERIQA Group et al. | 2001
- 178
-
PQP4: Cross-Cultural Variations in SF-12 Scores Among Individuals with Various Health ConditionsBolge, S. C. / Eschmann, B. / Donohue, J. A. et al. | 2001
- 178
-
PQP5: Translating SF-36 Scores into Preferences: An Examination of the Performance of Two Predictive EquationsMeletiche, D. M. / Roberts, C. S. / Lofland, J. H. et al. | 2001
- 178
-
PQP3: Defining Clinically Meaningful Change in Health-Related Quality of LifeCrosby, R. D. / Kolotkin, R. L. / Williams, G. R. et al. | 2001
- 179
-
PQP8: Evaluating Bias Introduced by Annualizing Utilization and Cost MeasuresZodet, M. / de Lissovoy, G. et al. | 2001
- 179
-
PQP6: Health Utilities Index Mark 3: Agreement Between Raters and Between Modalities of AdministrationVerrips, G. / den Ouden, A. / Bonsel, G. / Gemke, R. / Paneth, N. / Verloove-Vanhorick, S. et al. | 2001
- 179
-
PQP7: Is Compliance with Drug Treatment Correlated with Health Related Quality of Life?Cote, I. / Farris, K. B. / Feeny, D. H. et al. | 2001
- 180
-
PQP10: Negative Affectivity: A Significant Contaminant of Patient Reported Health Related Quality of Life Instruments (SF-36)Reed, P. J. / Moore, D. D. et al. | 2001
- 180
-
PQP9: Quality of Life Patients with Fabry DiseaseBotteman, M. F. / Pastores, G. M. / Gold, K. F. / Yeh, J. / Ali, J. / Aliski, W. / Pashos, C. L. et al. | 2001
- 181
-
PQP11: The Health and Work Questionnaire (HWQ): An Instrument for Assessing Workplace Productivity in Relation to Worker HealthShikiar, R. / Rentz, A. M. / Halpern, M. T. / Khan, Z. M. et al. | 2001
- 181
-
PMA1: Methodological Advances in the Assessment of Quality of Life in Clinical TrialsHufford, M. R. et al. | 2001
- 182
-
PMA3: Does Where You Life Affect If and How You Discount Future Costs and Benefits in Economic Evaluation? Should It?Faulkner, L. A. / Gafni, A. / O Brien, B. J. et al. | 2001
- 182
-
PMA2: Development of Cost-Effective Web-Based Outcomes Research Studies and Disease Management ProgramsAmbegaonkar, A. J. / Day, D. et al. | 2001
- 182
-
PMA4: An Economic Proof and Application That Formulary Restrictions Within Drug Classes Always Result in Higher CostsSimons, W. R. et al. | 2001
- 183
-
PMA7: Controlling for Biases from Measurement Errors in Health Outcomes Research Using Structural Equation ModelingShi, J. / McCombs, J. / Hay, J. / Nichol, M. / Chou, C. P. / Hsiao, C. et al. | 2001
- 183
-
PMA5: A Risk Adjustment Methodology for Claims DataWilson, P. / Yuan, Y. / Dowse, B. T. et al. | 2001
- 183
-
PMA6: The Reduction of Sample Size for a Cost-Effectiveness Trial Using a New Method: The Eight Cases in JapanKamae, I. / Yanagisawa, S. et al. | 2001
- 184
-
PMA8: Development of a Chronic Disease Indicator Using a Managed Care PopulationMalone, D. C. / Raebel, M. A. et al. | 2001
- 184
-
PMA9: Bayesian or Classical Design and Analysis: Does It Make a Difference?Bloom, B. S. et al. | 2001
- 185
-
PMA11: Comparison of Statistical Tests for the Cost/Effectiveness RatiosKim, S. / Moeschberger, M. / Pathak, D. et al. | 2001
- 185
-
PMA12: Relationship Between Nonparametric Receiver Operating Characteristic Analysis and a Likelihood-Ratio test for Model Selection: 1. A Monte Carlo Simulation Using Continuous DataShaw, J. W. / Horrace, W. / Coons, S. J. et al. | 2001
- 185
-
PMA10: Description of Cost/Effectiveness Ratio DistributionsKim, S. / Moeschberger, M. / Pathak, D. et al. | 2001
- 186
-
PMA13: Relationship Between Nonparametric Receiver Operating Characteristic Analysis and a Likelihood-Ratio Test for Model Selection: II. A Monte Carlo Simulation Using Discrete DataShaw, J. W. / Shahriar, J. / Horrace, W. et al. | 2001
- 186
-
PMA14: Bayesian Decision Analysis in Outcome Studies with Small Numbers of Events: A Simulation Based Prediction ApproachWang, J. / Davey, P. / MacDonald, T. et al. | 2001
- 187
-
PMA17: The European Service Mapping Schedule (ESMS): A New Instrument for Mental Health Services Research, Results of a French StudyAzorin, J. M. / Goudemand, M. / Toumi, M. / Johnson, S. / Pettersson, A. et al. | 2001
- 187
-
PMA15: Conducting Pharmacoeconomic Research in the Absence of Country-Specific DataMiller, B. / Rosner, A. J. / Becker, D. L. et al. | 2001
- 187
-
PMA16: Confirmation of the Decision Rules and Assumptions for a Model of Diabetes Treatment Using an Expert PanelCaro, J. / Salas, M. / Ward, A. / Sung, J. / Shah, A. et al. | 2001
- 188
-
PMA18: The Avandia Worldwide Awareness Registry (AWARE®): An Internet-Based Program for Evaluation of Clinical, Humanistic and Economic Outcomes of Patients with Type 2 DiabetesBakst, A. / Meletiche, D. M. / Arnold, R. / Harjono, H. / Najib, M. / Cobitz, A. et al. | 2001
- 188
-
WW1: Methodological Complexities in Using Administrative Claims Databases to Evaluate Quality of Care for Attention-Deficit/Hyperactivity DisorderHankin, C. S. / Wright, A. T. et al. | 2001
- 189
-
WW2: Using Linkable Clinical and Administrative Claims Data to Improve Outcomes Research: Selected Case Studies from Oncology and Diabetes MellitusMenzin, J. / Lang, K. et al. | 2001
- 189
-
WW4: A New Approach to Disease Modeling with Numerous Comparators and Multiple Decision TreesBecker, R. / Noe, L. / Gore, M. / Martino, S. et al. | 2001
- 189
-
WW3: Issues and Problems Encountered in Models on Prevention of Deep Venous Thrombosis (DVT)Annemans, L. / Lamotte, M. / Huybrechts, M. et al. | 2001
- 190
-
WW5: Creative Approaches to Modeling Life Expectancy Gains for Economic Evaluation Using Published DataWeinstein, M. C. / Appadoo, S. et al. | 2001
- 190
-
WW6: Conducting Cost-Benefit and Cost-Utility Analysis: A Conjoint Analysis ApproachHauber, A. B. / Bala, M. V. / Fehnel, S. E. et al. | 2001
- 191
-
WW7: Beyond Cost-Effectiveness: The Strategic Value of Productivity-Related Outcomes in Clinical Trials, Burden of Illness Studies, and Post-Marketing ResearchOzminkowski, R. J. / Goetzel, R. Z. / Crown, W. C. / Long, S. R. / Ling, D. et al. | 2001
- 191
-
WW8: Constructing Episodes of Care from Claims Data: Applications to Pharmacoeconomic and Outcomes ResearchHuse, D. / Portnoy, M. et al. | 2001
- 192
-
WW10: Multinational Economic Studies: Lessons Learned from Trial-Based and Modelling StudiesDrummond, M. F. / Grima, D. et al. | 2001
- 192
-
WW9: The Use of Multi-Attribute Analysis and Pair-Wise Comparisons for Group Decision-MakingHess, G. P. / Forman, E. et al. | 2001
- 192
-
WW11: Using Markov Decision Models to Develop Optimal Treatment Pathways: An IllustrationBala, M. V. / Mauskopf, J. A. et al. | 2001
- 193
-
WW14: Making Models BetterMatchar, D. B. / Samsa, G. P. / Parmigiani, G. et al. | 2001
- 193
-
WW12: Use of Medication Compliance Data in Outcome AnalysesCramer, J. A. / Urquhart, J. et al. | 2001
- 193
-
WW13: Challenges in Performing Meta Analysis in Heart Failure Outcomes ResearchMullins, C. D. / Weiss, S. / Fulda, T. et al. | 2001
- 194
-
WW15: Identifying the Impact of a Treatment on Outcomes and Costs Using Observational Data: Overcoming Selection BiasPolsky, D. / Glick, H. A. et al. | 2001
- 194
-
WW16: Patient Registries: Their Value in Outcomes ResearchRussell, M. W. et al. | 2001
- 195
-
WW18: The Role of Health State Experience in Longitudinal Conjoint Analysis of Patient PreferencesBingham, M. / Smith, G. et al. | 2001
- 195
-
WW17: Selecting Health-Related Quality-of-Life Measures: First PrinciplesErickson, P. et al. | 2001